Amphastar Pharmaceuticals Inc (STU:29A)
€ 43.12 -6.39 (-12.91%) Market Cap: 2.08 Bil Enterprise Value: 2.43 Bil PE Ratio: 17.05 PB Ratio: 3.59 GF Score: 89/100

Q3 2020 Amphastar Pharmaceuticals Inc Earnings Call Transcript

Nov 06, 2020 / 05:00PM GMT
Release Date Price: €16.9 (-1.74%)
Operator

Good morning, ladies and gentlemen, and welcome to the Amphastar third quarter earnings call. (Operator Instructions) As a reminder, this conference call may be recorded.

All statements in this press release and in the conference call referenced above that are not historical are forward-looking statements, including, among other things: statements relating to the company's expectations regarding future financial performance, backlogs, sales and marketing of its products, market size and growth; the timing of FDA filings or approvals, including the DMFs of ANP; the timing of the product launches, acquisitions and other matters related to its pipeline of product candidates; its share buyback program and other future events, such as the impact of the COVID-19 pandemic and related responses of business and governments to the pandemic on our operations and personnel; and on commercial activity and demand across the business operations and results of operations.

These statements are not historical facts but rather are based on Amphastarâs historical performance and its current expectations,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot